MCID: CHR283
MIFTS: 43

Chronic Inflammatory Demyelinating Polyneuropathy malady

Rare diseases, Neuronal diseases categories

Aliases & Classifications for Chronic Inflammatory Demyelinating Polyneuropathy

About this section
Sources:
32LifeMap Discovery®, 45NIH Rare Diseases, 46NINDS, 51Orphanet, 65UMLS, 28ICD10 via Orphanet, 66UMLS via Orphanet
See all sources

Aliases & Descriptions for Chronic Inflammatory Demyelinating Polyneuropathy:

Name: Chronic Inflammatory Demyelinating Polyneuropathy 32 45 46 51
Chronic Inflammatory Demyelinating Polyradiculoneuropathy 45 51
 
Cidp 45 51
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 65


Classifications:



Characteristics (Orphanet epidemiological data):

51
chronic inflammatory demyelinating polyneuropathy:
Inheritance: Not applicable; Age of onset: Childhood; Age of death: normal life expectancy


External Ids:

Orphanet51 2932
ICD10 via Orphanet28 G61.8
UMLS via Orphanet66 C0393819

Summaries for Chronic Inflammatory Demyelinating Polyneuropathy

About this section
NINDS:46 Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms. The disorder, which is sometimes called chronic relapsing polyneuropathy, is caused by damage to the myelin sheath (the fatty covering that wraps around and protects nerve fibers) of the peripheral nerves. Although it can occur at any age and in both genders, CIDP is more common in young adults, and in men more so than women. It often presents with symptoms that include tingling or numbness (beginning in the toes and fingers), weakness of the arms and legs, loss of deep tendon reflexes (areflexia), fatigue, and abnormal sensations. CIDP is closely related to Guillain-Barre syndrome and it is considered the chronic counterpart of that acute disease.

MalaCards based summary: Chronic Inflammatory Demyelinating Polyneuropathy, also known as chronic inflammatory demyelinating polyradiculoneuropathy, is related to demyelinating polyneuropathy and polyneuropathy. An important gene associated with Chronic Inflammatory Demyelinating Polyneuropathy is AIF1 (Allograft Inflammatory Factor 1). The drug immunoglobulins, intravenous has been mentioned in the context of this disorder. Affiliated tissues include t cells, bone and skin, and related mouse phenotypes are hematopoietic system and immune system.

NIH Rare Diseases:45 Chronic inflammatory demyelinating polyneuropathy (cidp) is a neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms. the disorder is caused by damage to the myelin sheath (the fatty covering that wraps around and protects nerve fibers) of the peripheral nerves. it often presents with symptoms that include tingling or numbness (beginning in the toes and fingers), weakness of the arms and legs, loss of deep tendon reflexes, fatigue, and abnormal sensations. cidp is closely related to guillain-barre syndrome and it is considered the chronic counterpart of that acute disease. treatment may include corticosteroids, immunosuppressant drugs, plasma exchange, physiotherapy, and/or intravenous immunoglobulin (ivig) therapy. last updated: 8/1/2012

Wikipedia:68 Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated inflammatory... more...

Related Diseases for Chronic Inflammatory Demyelinating Polyneuropathy

About this section

Diseases in the Demyelinating Polyneuropathy family:

chronic inflammatory demyelinating polyneuropathy Subacute Inflammatory Demyelinating Polyneuropathy

Diseases related to Chronic Inflammatory Demyelinating Polyneuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 182)
idRelated DiseaseScoreTop Affiliating Genes
1demyelinating polyneuropathy11.6
2polyneuropathy11.6
3neuropathy11.0
4demyelinating disease10.8
5peripheral neuropathy10.8
6critical illness polyneuropathy10.8
7chronic inflammatory demyelinating polyradiculoneuropathy10.8
8autoimmune disease of the nervous system10.8
9chronic polyneuropathy10.8
10hypersensitivity reaction type ii disease10.8
11neuromuscular disease10.8
12peripheral nervous system disease10.8
13polyradiculoneuropathy10.8
14neurologic diseases10.8
15autoimmune disease 210.7
16autoimmune disease 310.7
17neuropathy, inflammatory demyelinating10.7
18autoimmune disease 110.7
19hepatitis10.7
20influenza10.7
21charcot-marie-tooth disease10.6
22myasthenia gravis10.6
23melanoma10.6
24tooth disease10.6
25autoimmune disease 410.6
26gamma chain deficiency10.6
27motor peripheral neuropathy10.6
28poems syndrome10.6
29myopathy10.6
30glomerulonephritis10.5
31hepatitis b10.5
32multifocal motor neuropathy10.5
33adjustment disorder10.5
34autoimmune disease of blood10.5
35nervous system disease10.5
36respiratory failure10.5
37withdrawal disorder10.5
38neuritis10.5
39autonomic dysfunction10.5
40dawson disease10.5
41systemic lupus erythematosus10.4
42influenza, severe10.4
43charcot-marie-tooth disease, type 1a10.4
44arthritis10.4
45diabetic neuropathy10.4
46focal segmental glomerulosclerosis10.4
47muscle disorders10.4
48autoimmune disease of central nervous system10.4
49diabetic polyneuropathy10.4
50mononeuritis multiplex10.4

Graphical network of the top 20 diseases related to Chronic Inflammatory Demyelinating Polyneuropathy:



Diseases related to chronic inflammatory demyelinating polyneuropathy

Symptoms for Chronic Inflammatory Demyelinating Polyneuropathy

About this section

Drugs & Therapeutics for Chronic Inflammatory Demyelinating Polyneuropathy

About this section

Drugs for Chronic Inflammatory Demyelinating Polyneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
alemtuzumabapproved, investigationalPhase 4293216503-57-0
Synonyms:
Campath
 
Lemtrada
Mabcampath
alemtuzumab
2Rho(D) Immune GlobulinPhase 4, Phase 3, Phase 2198
3Immunoglobulins, IntravenousPhase 4, Phase 3, Phase 2203
4
PrednisoneapprovedPhase 3120853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
5
Mycophenolic acidapprovedPhase 386424280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Melbex
 
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic Acid
Mycophenolsaeure
Myfortic
6
Fingolimodapproved, investigationalPhase 382162359-55-9107970
Synonyms:
2-Amino-2-(4-octylphenethyl)propane-1,3-diol
AC1L332W
CHEBI:244940
CHEMBL314854
CID107970
FTY720
Fingolimod
 
Fingolimod Hydrochloride
Fingolimodum
Gilenya
LS-187221
MolPort-003-847-513
UNII-3QN8BYN5QF
nchembio.547-comp4
nchembio804-comp4
7
Mycophenolate mofetilapproved, investigationalPhase 3864128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate Mofetil
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
8
Glycineapproved, nutraceuticalPhase 310256-40-6750
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2-Aminoacetate
2-Aminoacetic acid
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB-131/40217813
AB1002628
AC1L19XW
AC1Q28JW
AC1Q53O0
AI3-04085
AKOS000119626
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AR-1A0345
AR-1A0532
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
Amino-Acetate
Amino-Acetic acid
Aminoacetate
Aminoacetic acid
Aminoazijnzuur
Aminoessigsaeure
Aminoethanoate
Aminoethanoic acid
Amitone
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
BPBio1_001222
Biomol-NT_000195
C00037
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
CPD-8569
Corilin
D00011
DB00145
EINECS 200-272-2
 
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
GLY (IUPAC abbrev)
GLYCINE 1.5% IN PLASTIC CONTAINER
GLYCINE, ACS
Glicina
Glicina [INN-Spanish]
Glicoamin
Gly
Glycin
Glycine
Glycine (JP15/USP)
Glycine [INN]
Glycine iron sulphate (1:1)
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, non-medical
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-Hydralin
Gyn-hydralin
H-Gly-OH
H2N-CH2-COOH
HSDB 495
Hampshire glycine
Hgly
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L-Glycine
L-alpha-amino acids
L001246
LS-218
Leimzucker
MolPort-000-871-607
NCGC00024503-01
NCGC00024503-02
NChemBio.2007.13-comp1
NSC 25936
NSC25936
P8791_SIGMA
Padil
Polyglycine II
S04-0135
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
aminoacetic acid
an alpha amino acid ester
bmse000089
gly
glycine
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
nchembio.265-comp9
nchembio.266-comp30
polyglycine
9Immunoglobulin GPhase 3167
10AlbunexPhase 3145
11
Folic Acidapproved, nutraceuticalPhase 2285159-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
12Vitamin B ComplexPhase 22775
13Thioctic AcidPhase 297
14Interferon beta 1aPhase 2191
15Interferon-betaPhase 2244
16beta-endorphinPhase 289
17Adrenocorticotropic HormonePhase 2121
18Alpha-lipoic AcidNutraceuticalPhase 297
19Vitamin B9NutraceuticalPhase 22851
20FolateNutraceuticalPhase 22851
21Gamma-Globulins22

Interventional clinical trials:

(show all 37)
idNameStatusNCT IDPhase
1Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)RecruitingNCT01757574Phase 4
2IVIg for Demyelination in Diabetes MellitusRecruitingNCT02372149Phase 4
3Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.CompletedNCT01824251Phase 3
4Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT01184846Phase 3
5Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIgCompletedNCT01349270Phase 3
6Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00220740Phase 3
7Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00004772Phase 3
8Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3
9Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNCT00004939Phase 3
10Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.RecruitingNCT01625182Phase 3
11Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDPRecruitingNCT02549170Phase 3
12Efficacy and Safety Study of I10E in Treatment of Patients With CIDPRecruitingNCT02293460Phase 3
13Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302RecruitingNCT02317562Phase 3
14Interest of Mycophenolate for CIDP WeaningRecruitingNCT02494505Phase 3
15Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)Active, not recruitingNCT01545076Phase 3
16Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Enrolling by invitationNCT02027701Phase 3
17Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) NeuropathyNot yet recruitingNCT02638207Phase 3
18Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDPTerminatedNCT01225276Phase 2, Phase 3
19Lipoic Acid to Treat Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00962429Phase 2
20Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
21Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT00099489Phase 2
22Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT01017159Phase 2
23Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT00278629Phase 2
24Stem Cell Transplantation for Stiff Person Syndrome (SPS)RecruitingNCT02282514Phase 1, Phase 2
25Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyNot yet recruitingNCT02574962Phase 2
26High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating PolyneuropathyWithdrawnNCT01236456Phase 2
27Immunoglobulin Dosage and Administration Form in CIDP and MMNCompletedNCT02111590
28Study of CIDP Patients During IVIG TreatmentCompletedNCT00305266
29Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT01379833
30Subcutaneous Immunoglobulin for CIDPRecruitingNCT02465359
31IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength MeasurementsRecruitingNCT02414490
32sCD163 & CD19 as Candidate Biomarkers in CIDP and MMNRecruitingNCT02271724
33Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT02629796
34Transcriptome Analysis of the Peripheral Blood in CIDPRecruitingNCT02404298
35Magnetic Resonance Diagnostics of Diabetic Peripheral NeuropathyRecruitingNCT01847937
36Effect of Resistance and Aerobic Exercise in CIDP or MMNEnrolling by invitationNCT02121678
37MRI in Diagnosing and Monitoring CIDPEnrolling by invitationNCT02017769

Search NIH Clinical Center for Chronic Inflammatory Demyelinating Polyneuropathy

Inferred drug relations via UMLS65/NDF-RT43:

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Chronic Inflammatory Demyelinating Polyneuropathy:
Hematopoietic stem cells for treatment of chronic inflammatory demyelinating polyneuropathy
Embryonic/Adult Cultured Cells Related to Chronic Inflammatory Demyelinating Polyneuropathy:
Bone marrow-derived hematopoietic stem cells, PMID: 17277794

Genetic Tests for Chronic Inflammatory Demyelinating Polyneuropathy

About this section

Anatomical Context for Chronic Inflammatory Demyelinating Polyneuropathy

About this section

MalaCards organs/tissues related to Chronic Inflammatory Demyelinating Polyneuropathy:

33
T cells, Bone, Skin, Spinal cord, Endothelial, B cells, Thyroid

Animal Models for Chronic Inflammatory Demyelinating Polyneuropathy or affiliated genes

About this section

MGI Mouse Phenotypes related to Chronic Inflammatory Demyelinating Polyneuropathy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.9AIF1, APOA4, FYB, GAS6, HP
2MP:00053877.6AIF1, APOA4, FYB, GAS6, HP

Publications for Chronic Inflammatory Demyelinating Polyneuropathy

About this section

Articles related to Chronic Inflammatory Demyelinating Polyneuropathy:

(show top 50)    (show all 479)
idTitleAuthorsYear
1
Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies and questions. (26425012)
2015
2
Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy. (25814494)
2015
3
Genetic Creutzfeldt-Jakob disease mimicking chronic inflammatory demyelinating polyneuropathy. (26568971)
2015
4
A case of cauda equina syndrome in early-onset chronic inflammatory demyelinating polyneuropathy clinically similar to charcot-marie-tooth disease type 1. (25237436)
2014
5
Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide. (23168526)
2013
6
Chronic inflammatory demyelinating polyneuropathy and metastatic melanoma. (23968958)
2013
7
Efficacy and safety of Privigen(Ar) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). (23781960)
2013
8
Brucellosis manifesting as chronic inflammatory demyelinating polyneuropathy. (22728867)
2012
9
Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. (22190302)
2012
10
Comment on acute-onset chronic inflammatory demyelinating polyneuropathy versus fluctuating Guillain-BarrAc syndrome. (21922476)
2011
11
Diagnostic and therapeutic challenges in chronic inflammatory demyelinating polyneuropathy and other immune-mediated neuropathies. (21157311)
2011
12
Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies. (19922956)
2010
13
Atypical childhood chronic inflammatory demyelinating polyneuropathy. (20589891)
2010
14
Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. (20049473)
2010
15
Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy. (20176598)
2010
16
The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-BarrAc syndrome from chronic inflammatory demyelinating polyneuropathy. (20538476)
2010
17
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. (21199104)
2010
18
Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV. (19260050)
2009
19
Transient oculomotor palsy correlated with nerve enhancement on MRI in chronic inflammatory demyelinating polyneuropathy. (19915301)
2009
20
Fatigue in chronic inflammatory demyelinating polyneuropathy. (19347932)
2009
21
Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. (19252365)
2009
22
Motor variant of chronic inflammatory demyelinating polyneuropathy in a child. (18486826)
2008
23
Post-influenza vaccine chronic inflammatory demyelinating polyneuropathy. (17993473)
2008
24
A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy. (17306302)
2007
25
Chronic inflammatory demyelinating polyneuropathy associated with intestinal tuberculosis. (17712474)
2007
26
Treatment-responsive pudendal dysfunction in chronic inflammatory demyelinating polyneuropathy. (17372137)
2007
27
High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy. (15703014)
2005
28
Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin. (16024890)
2005
29
Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. (16325658)
2005
30
Chronic inflammatory demyelinating polyneuropathy after Campylobacter jejuni infection mimicking vasculitic mononeuritis multiplex in a diabetic. (15104697)
2004
31
Chronic Inflammatory Demyelinating Polyneuropathy. (12895398)
2003
32
Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. (12507413)
2003
33
Subarachnoid block for a patient with progressive chronic inflammatory demyelinating polyneuropathy. (11682419)
2001
34
Clinical and magnetic resonance imaging evidence of brain and spinal cord demyelination in a case of chronic inflammatory demyelinating polyneuropathy. (11437170)
2001
35
Activity-dependent excitability changes in chronic inflammatory demyelinating polyneuropathy: A microneurographic study. (10398208)
1999
36
Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers. (10555828)
1999
37
Chronic inflammatory demyelinating polyneuropathy (CIDP). (10689499)
1999
38
Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP). (9845290)
1998
39
Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy. (9109870)
1997
40
Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. (8902721)
1996
41
Treatment of patients with chronic inflammatory demyelinating polyneuropathy. (8881435)
1996
42
Chronic inflammatory demyelinating polyneuropathy. (8907837)
1994
43
Magnetic resonance imaging of the cauda equina in chronic inflammatory demyelinating polyneuropathy. (8388677)
1993
44
Serum and CSF anti-GM1 antibodies in patients with Guillain-BarrAc syndrome and chronic inflammatory demyelinating polyneuropathy. (8433097)
1993
45
Chronic inflammatory demyelinating polyneuropathy in childhood: clinical and electrophysiological features. (1657385)
1991
46
CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study. (1935761)
1991
47
Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy. (2597997)
1989
48
Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid-responsive disorder. (3017185)
1986
49
Plasma exchange as sole treatment for chronic inflammatory demyelinating polyneuropathy. (3702800)
1986
50
Chronic inflammatory demyelinating polyneuropathy. (4086221)
1985

Variations for Chronic Inflammatory Demyelinating Polyneuropathy

About this section

Expression for genes affiliated with Chronic Inflammatory Demyelinating Polyneuropathy

About this section
Search GEO for disease gene expression data for Chronic Inflammatory Demyelinating Polyneuropathy.

Pathways for genes affiliated with Chronic Inflammatory Demyelinating Polyneuropathy

About this section

GO Terms for genes affiliated with Chronic Inflammatory Demyelinating Polyneuropathy

About this section

Cellular components related to Chronic Inflammatory Demyelinating Polyneuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1blood microparticleGO:00725629.9APOA4, HP
2endoplasmic reticulum lumenGO:00057889.2APOA4, GAS6
3extracellular spaceGO:00056158.1APOA4, GAS6, HP, IFNA2
4extracellular regionGO:00055767.8APOA4, GAS6, HP, IFNA2

Biological processes related to Chronic Inflammatory Demyelinating Polyneuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of protein phosphorylationGO:00019349.7AIF1, GAS6
2negative regulation of gene expressionGO:00106299.4AIF1, IFNA2
3defense responseGO:00069529.2HP, IFNA2

Molecular functions related to Chronic Inflammatory Demyelinating Polyneuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1antioxidant activityGO:00162099.4APOA4, HP

Sources for Chronic Inflammatory Demyelinating Polyneuropathy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet